Core Insights - Southbound funds increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 4.17 million shares on November 18, 2025, bringing the total holdings to 1.45 billion shares, which represents 52.58% of the company's issued ordinary shares [1][2] Group 1: Shareholding Changes - Over the past five trading days, there were two days of net reductions in holdings by southbound funds, totaling a net decrease of 686,700 shares [1] - In the last 20 trading days, there were ten days of net increases in holdings by southbound funds, with a cumulative net increase of 8.73 million shares [1] Group 2: Company Overview - Jinxin Reproductive Medicine is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, and sales of medical consumables and equipment [2] - The company's services are mainly provided in China and the United States [2]
锦欣生殖（01951.HK）：11月18日南向资金增持417万股